II
TBPH icon

Inspire Investing’s Theravance Biopharma TBPH Stock Holding History

Inspire Investing’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68,526
Closed -$1.28M – 1161
2025
Q4 		$1.28M Sell
68,526
-5,030
-7% -$83.4K 0.12% 196
2025
Q3 		$1.07M Buy
+73,556
New +$929K 0.1% 206
2021
Q1 		– Sell
-11,718
Closed -$208K – 716
2020
Q4 		$208K Buy
+11,718
New +$210K 0.05% 608
2020
Q3 		– Sell
-9,672
Closed -$203K – 563
2020
Q2 		$203K Buy
9,672
+710
+8% +$18.2K 0.07% 451
2020
Q1 		$207K Buy
+8,962
New +$224K 0.08% 414
2019
Q4 		– Sell
-11,147
Closed -$217K – 372
2019
Q3 		$217K Buy
11,147
+942
+9% +$19K 0.08% 259
2019
Q2 		$167K Buy
+10,205
New +$207K 0.07% 311
2018
Q1 		– Sell
-2,013
Closed -$56K – 640
2017
Q4 		$56K Buy
+2,013
New +$59.6K 0.05% 577

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Inspire Investing's TBPH Position: Q1 2026 in Review

Inspire Investing sold out of Theravance Biopharma (TBPH) in Q1 2026, closing a stake of 68,526 shares — an estimated $1.28M sold.

Inspire Investing first reported a position in TBPH in Q4 2017 and held it in 8 quarters. The position peaked at $1.28M in Q4 2025. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Inspire Investing reported no remaining Theravance Biopharma position as of Q1 2026 after selling out during the quarter.
  • Inspire Investing sold 68,526 Theravance Biopharma shares in Q1 2026, an estimated $1.28M.
  • Inspire Investing first reported a position in Theravance Biopharma in Q4 2017 and held it in 8 quarters.
  • Inspire Investing's Theravance Biopharma position peaked at $1.28M in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.